Alcoholic hepatitis natural history, complications and prognosis

Revision as of 17:21, 1 February 2013 by Shankar Kumar (talk | contribs)
Jump to navigation Jump to search

Alcoholic hepatitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Alcoholic hepatitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Alcoholic hepatitis natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Alcoholic hepatitis natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Alcoholic hepatitis natural history, complications and prognosis

CDC on Alcoholic hepatitis natural history, complications and prognosis

Alcoholic hepatitis natural history, complications and prognosis in the news

Blogs on Alcoholic hepatitis natural history, complications and prognosis

Directions to Hospitals Treating Alcoholic hepatitis

Risk calculators and risk factors for Alcoholic hepatitis natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Assosciate Editor(s)-In-Chief: Prashanth Saddala M.B.B.S

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Prognosis

  • Poor prognostic factors include:
  • Discriminant function, as described above, is a predictor or severity.
    • DF > 32 – Mortality 35% without steroids, in patients without encephalopathy. Mortality 45% in patients with encephalopathy.
  • Abstinence appears to help slow or stop the progression of alcohol associated liver disease.
    • In patients with advanced disease, cirrhosis can develop in patients who stop, but is much more likely to develop in those patients who continue to drink.
  • Maddrey, et al #maddrey described the Discriminant Function (DF) formula to determine patients who might respond:
    DF = 4.6 x (PT – control PT) + Total Bilirubin
    • DF > 32 has been been associated with a high death rate, up to 50% in some studies, with improved prognosis with steroid treatment.
    • A recent study showed a fall in one month mortality from 35 to 6%. Another showed a fall in six month mortality 55 to 16%.
    • Effect on long term mortality not clear

References

Template:WikiDoc Sources